Review





Similar Products

99
ATCC acute t cell leukemia
Acute T Cell Leukemia, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pm42981192-239-9-15
Average 99 stars, based on 1 article reviews
acute t cell leukemia - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human t cell lines cem12d7
Human T Cell Lines Cem12d7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pm42954482-288-0-7
Average 99 stars, based on 1 article reviews
human t cell lines cem12d7 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

97
DSMZ human t cell leukemia cells
Human T Cell Leukemia Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/JURKAT/pm42921456-91-16-22
Average 97 stars, based on 1 article reviews
human t cell leukemia cells - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
ATCC human cd4 t lymphoblastoid jurkat cells
Human Cd4 T Lymphoblastoid Jurkat Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pmc13769488-201-0-8
Average 99 stars, based on 1 article reviews
human cd4 t lymphoblastoid jurkat cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC jurkat t cell line
( A–C ) Estimation of nuclear translocation of NFAT. ( A ) Western blot showing nuclear translocation of NFAT in <t>Jurkat</t> <t>T</t> cells treated with Scr or STX11 shRNA and stimulated with PMA +TG. N=3. ( B ) Representative confocal images of control and STX11-depleted Jurkat T cells stimulated with anti-CD3, immunolabeled with anti-NFAT1 antibody, and counter-stained with DAPI. (N=3) ( C ) Box and whisker plot showing quantification of nuclear NFAT from cells populating 10 randomly chosen fields per group in ( B ). ( D ) Quantification of IL-2 mRNA in anti-CD3 stimulated Jurkat T cells treated with Scr or STX11 shRNA using qPCR. The bars show mean ± SE of relative IL-2 mRNA. N=3. ( E ) Quantification of IL-2 EIA on supernatants of Scr (black) or STX11 (red) shRNA-treated Jurkat T cells stimulated with anti-CD3. ( F ) qPCR analysis of IL-2 mRNA expression in various stimulated HD (black) and FHLH4 T cells (red). ( G–H ) Flow cytometry contour plot showing granule release assay performed on HD (black) and FHLH4 CD8 T (red) cells ( G ) and its quantification ( H ). Figure 4—source data 1. Folder containing labeled PDF files of original western blots for . Figure 4—source data 2. Folder containing the original images of western blots shown in . Figure 4—source data 3. Numerical data underlying the quantitative analyses represented in . Figure 4—source data 4. Folder containing the original flow cytometry files and gating strategy for Figure 4G .
Jurkat T Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pmc13679927-109-7-14
Average 99 stars, based on 1 article reviews
jurkat t cell line - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC jurkat t cells
( A–C ) Estimation of nuclear translocation of NFAT. ( A ) Western blot showing nuclear translocation of NFAT in <t>Jurkat</t> <t>T</t> cells treated with Scr or STX11 shRNA and stimulated with PMA +TG. N=3. ( B ) Representative confocal images of control and STX11-depleted Jurkat T cells stimulated with anti-CD3, immunolabeled with anti-NFAT1 antibody, and counter-stained with DAPI. (N=3) ( C ) Box and whisker plot showing quantification of nuclear NFAT from cells populating 10 randomly chosen fields per group in ( B ). ( D ) Quantification of IL-2 mRNA in anti-CD3 stimulated Jurkat T cells treated with Scr or STX11 shRNA using qPCR. The bars show mean ± SE of relative IL-2 mRNA. N=3. ( E ) Quantification of IL-2 EIA on supernatants of Scr (black) or STX11 (red) shRNA-treated Jurkat T cells stimulated with anti-CD3. ( F ) qPCR analysis of IL-2 mRNA expression in various stimulated HD (black) and FHLH4 T cells (red). ( G–H ) Flow cytometry contour plot showing granule release assay performed on HD (black) and FHLH4 CD8 T (red) cells ( G ) and its quantification ( H ). Figure 4—source data 1. Folder containing labeled PDF files of original western blots for . Figure 4—source data 2. Folder containing the original images of western blots shown in . Figure 4—source data 3. Numerical data underlying the quantitative analyses represented in . Figure 4—source data 4. Folder containing the original flow cytometry files and gating strategy for Figure 4G .
Jurkat T Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pm42865485-102-4-9
Average 99 stars, based on 1 article reviews
jurkat t cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human leukemia jurkat t cells
( A–C ) Estimation of nuclear translocation of NFAT. ( A ) Western blot showing nuclear translocation of NFAT in <t>Jurkat</t> <t>T</t> cells treated with Scr or STX11 shRNA and stimulated with PMA +TG. N=3. ( B ) Representative confocal images of control and STX11-depleted Jurkat T cells stimulated with anti-CD3, immunolabeled with anti-NFAT1 antibody, and counter-stained with DAPI. (N=3) ( C ) Box and whisker plot showing quantification of nuclear NFAT from cells populating 10 randomly chosen fields per group in ( B ). ( D ) Quantification of IL-2 mRNA in anti-CD3 stimulated Jurkat T cells treated with Scr or STX11 shRNA using qPCR. The bars show mean ± SE of relative IL-2 mRNA. N=3. ( E ) Quantification of IL-2 EIA on supernatants of Scr (black) or STX11 (red) shRNA-treated Jurkat T cells stimulated with anti-CD3. ( F ) qPCR analysis of IL-2 mRNA expression in various stimulated HD (black) and FHLH4 T cells (red). ( G–H ) Flow cytometry contour plot showing granule release assay performed on HD (black) and FHLH4 CD8 T (red) cells ( G ) and its quantification ( H ). Figure 4—source data 1. Folder containing labeled PDF files of original western blots for . Figure 4—source data 2. Folder containing the original images of western blots shown in . Figure 4—source data 3. Numerical data underlying the quantitative analyses represented in . Figure 4—source data 4. Folder containing the original flow cytometry files and gating strategy for Figure 4G .
Human Leukemia Jurkat T Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pmc13748593-252-1-8
Average 99 stars, based on 1 article reviews
human leukemia jurkat t cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human t lymphocyte cell line jurkat
( A–C ) Estimation of nuclear translocation of NFAT. ( A ) Western blot showing nuclear translocation of NFAT in <t>Jurkat</t> <t>T</t> cells treated with Scr or STX11 shRNA and stimulated with PMA +TG. N=3. ( B ) Representative confocal images of control and STX11-depleted Jurkat T cells stimulated with anti-CD3, immunolabeled with anti-NFAT1 antibody, and counter-stained with DAPI. (N=3) ( C ) Box and whisker plot showing quantification of nuclear NFAT from cells populating 10 randomly chosen fields per group in ( B ). ( D ) Quantification of IL-2 mRNA in anti-CD3 stimulated Jurkat T cells treated with Scr or STX11 shRNA using qPCR. The bars show mean ± SE of relative IL-2 mRNA. N=3. ( E ) Quantification of IL-2 EIA on supernatants of Scr (black) or STX11 (red) shRNA-treated Jurkat T cells stimulated with anti-CD3. ( F ) qPCR analysis of IL-2 mRNA expression in various stimulated HD (black) and FHLH4 T cells (red). ( G–H ) Flow cytometry contour plot showing granule release assay performed on HD (black) and FHLH4 CD8 T (red) cells ( G ) and its quantification ( H ). Figure 4—source data 1. Folder containing labeled PDF files of original western blots for . Figure 4—source data 2. Folder containing the original images of western blots shown in . Figure 4—source data 3. Numerical data underlying the quantitative analyses represented in . Figure 4—source data 4. Folder containing the original flow cytometry files and gating strategy for Figure 4G .
Human T Lymphocyte Cell Line Jurkat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pm42867569-213-12-25
Average 99 stars, based on 1 article reviews
human t lymphocyte cell line jurkat - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC t lymphoblast jurkat e6 1 cells
( A–C ) Estimation of nuclear translocation of NFAT. ( A ) Western blot showing nuclear translocation of NFAT in <t>Jurkat</t> <t>T</t> cells treated with Scr or STX11 shRNA and stimulated with PMA +TG. N=3. ( B ) Representative confocal images of control and STX11-depleted Jurkat T cells stimulated with anti-CD3, immunolabeled with anti-NFAT1 antibody, and counter-stained with DAPI. (N=3) ( C ) Box and whisker plot showing quantification of nuclear NFAT from cells populating 10 randomly chosen fields per group in ( B ). ( D ) Quantification of IL-2 mRNA in anti-CD3 stimulated Jurkat T cells treated with Scr or STX11 shRNA using qPCR. The bars show mean ± SE of relative IL-2 mRNA. N=3. ( E ) Quantification of IL-2 EIA on supernatants of Scr (black) or STX11 (red) shRNA-treated Jurkat T cells stimulated with anti-CD3. ( F ) qPCR analysis of IL-2 mRNA expression in various stimulated HD (black) and FHLH4 T cells (red). ( G–H ) Flow cytometry contour plot showing granule release assay performed on HD (black) and FHLH4 CD8 T (red) cells ( G ) and its quantification ( H ). Figure 4—source data 1. Folder containing labeled PDF files of original western blots for . Figure 4—source data 2. Folder containing the original images of western blots shown in . Figure 4—source data 3. Numerical data underlying the quantitative analyses represented in . Figure 4—source data 4. Folder containing the original flow cytometry files and gating strategy for Figure 4G .
T Lymphoblast Jurkat E6 1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jurkat+t/Jurkat%2C+Clone+E6-1/pmc13616249-166-7-16
Average 99 stars, based on 1 article reviews
t lymphoblast jurkat e6 1 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


( A–C ) Estimation of nuclear translocation of NFAT. ( A ) Western blot showing nuclear translocation of NFAT in Jurkat T cells treated with Scr or STX11 shRNA and stimulated with PMA +TG. N=3. ( B ) Representative confocal images of control and STX11-depleted Jurkat T cells stimulated with anti-CD3, immunolabeled with anti-NFAT1 antibody, and counter-stained with DAPI. (N=3) ( C ) Box and whisker plot showing quantification of nuclear NFAT from cells populating 10 randomly chosen fields per group in ( B ). ( D ) Quantification of IL-2 mRNA in anti-CD3 stimulated Jurkat T cells treated with Scr or STX11 shRNA using qPCR. The bars show mean ± SE of relative IL-2 mRNA. N=3. ( E ) Quantification of IL-2 EIA on supernatants of Scr (black) or STX11 (red) shRNA-treated Jurkat T cells stimulated with anti-CD3. ( F ) qPCR analysis of IL-2 mRNA expression in various stimulated HD (black) and FHLH4 T cells (red). ( G–H ) Flow cytometry contour plot showing granule release assay performed on HD (black) and FHLH4 CD8 T (red) cells ( G ) and its quantification ( H ). Figure 4—source data 1. Folder containing labeled PDF files of original western blots for . Figure 4—source data 2. Folder containing the original images of western blots shown in . Figure 4—source data 3. Numerical data underlying the quantitative analyses represented in . Figure 4—source data 4. Folder containing the original flow cytometry files and gating strategy for Figure 4G .

Journal: eLife

Article Title: Syntaxin11 deficiency inhibits CRAC channel priming to suppress cytotoxicity and gene expression in T lymphocytes independent of membrane trafficking

doi: 10.7554/eLife.111335

Figure Lengend Snippet: ( A–C ) Estimation of nuclear translocation of NFAT. ( A ) Western blot showing nuclear translocation of NFAT in Jurkat T cells treated with Scr or STX11 shRNA and stimulated with PMA +TG. N=3. ( B ) Representative confocal images of control and STX11-depleted Jurkat T cells stimulated with anti-CD3, immunolabeled with anti-NFAT1 antibody, and counter-stained with DAPI. (N=3) ( C ) Box and whisker plot showing quantification of nuclear NFAT from cells populating 10 randomly chosen fields per group in ( B ). ( D ) Quantification of IL-2 mRNA in anti-CD3 stimulated Jurkat T cells treated with Scr or STX11 shRNA using qPCR. The bars show mean ± SE of relative IL-2 mRNA. N=3. ( E ) Quantification of IL-2 EIA on supernatants of Scr (black) or STX11 (red) shRNA-treated Jurkat T cells stimulated with anti-CD3. ( F ) qPCR analysis of IL-2 mRNA expression in various stimulated HD (black) and FHLH4 T cells (red). ( G–H ) Flow cytometry contour plot showing granule release assay performed on HD (black) and FHLH4 CD8 T (red) cells ( G ) and its quantification ( H ). Figure 4—source data 1. Folder containing labeled PDF files of original western blots for . Figure 4—source data 2. Folder containing the original images of western blots shown in . Figure 4—source data 3. Numerical data underlying the quantitative analyses represented in . Figure 4—source data 4. Folder containing the original flow cytometry files and gating strategy for Figure 4G .

Article Snippet: Cell line ( Homo sapiens ) , Jurkat T cell line [Clone E6-1] , ATCC , TIB-152 (RRID: CVCL_0367 ) , — and and associated figure supplements .

Techniques: Translocation Assay, Western Blot, shRNA, Confocal, Control, Immunolabeling, Staining, Whisker Assay, Analysis, Expressing, Flow Cytometry, Release Assay, Labeling, Immunofluorescence, Real-time Polymerase Chain Reaction, FACS

Measurement of SOCE in STX11-depleted Jurkat and FHLH4 patient T cells. ( A–B ) Representative Fura-2 calcium imaging assay ( A ) and quantification of independent repeats ( B ) measuring thapsigargin (TG) induced SOCE in Jurkat T cells treated with Scr (black), STX11#1 (red) or STX11#2 (blue) shRNAs. (n=30–40 cells/group, N=3). ( C–D ) Representative Fura-2 calcium imaging assay ( C ) and quantification of repeats ( D ) showing reconstitution of SOCE in STX11-depleted Jurkat T cells by ectopic expression of STX11. Scr shRNA with empty vector (EV) expression (black), STX11 shRNA with EV expression (red), STX11 shRNA with STX11 expression (green). (n=30–40 cells/group, N=3). ( E ) Sanger sequencing of FHLH4 patient DNA showing deletion of a single adenine at the 752nd position and the resulting frameshift. ( F ) Schematic showing the predicted domain distribution of the wildtype versus FHLH4 mutant STX11 protein. ( G ) Western blot on WCLs of healthy donor (HD) and FHLH4 patient PBMCs showing the relative molecular weight and abundance of the wildtype and mutant STX11 bands (red arrow). ( H ) Western blot on WCLs of HEK293 cells over-expressing wildtype or FHLH4 mutant STX11 (red arrow) and empty vector. ( I ) Fura-2 calcium imaging assay measuring anti-CD3 induced SOCE in HD (black) and FHLH4 (red) T cells. (n=30–40 cells/group). ( J ) Fura-2 calcium imaging assay measuring SOCE in HD expressing empty vector (EV) (black) and FHLH4 T cells expressing human STX11 (red), respectively. (n=30–40 cells/group). ( K–L ) Representative Fura-2 calcium imaging assay ( K ) and quantification of repeats ( L ) measuring SOCE in Jurkat T cells treated either with Scr shRNA expressing empty vector (EV) (black), STX11 shRNA expressing EV (red), STX11 shRNA expressing wildtype STX11 (green), or STX11 shRNA expressing FHLH4 mutant STX11 (blue). Figure 1—source data 1. Numerical data underlying the quantitative analyses represented in . Figure 1—source data 2. Folder containing the original sequencing result files, shown in . Figure 1—source data 3. Folder containing labeled PDF files of the original western blots for . Figure 1—source data 4. Folder containing the original images of western blots displayed in .

Journal: eLife

Article Title: Syntaxin11 deficiency inhibits CRAC channel priming to suppress cytotoxicity and gene expression in T lymphocytes independent of membrane trafficking

doi: 10.7554/eLife.111335

Figure Lengend Snippet: Measurement of SOCE in STX11-depleted Jurkat and FHLH4 patient T cells. ( A–B ) Representative Fura-2 calcium imaging assay ( A ) and quantification of independent repeats ( B ) measuring thapsigargin (TG) induced SOCE in Jurkat T cells treated with Scr (black), STX11#1 (red) or STX11#2 (blue) shRNAs. (n=30–40 cells/group, N=3). ( C–D ) Representative Fura-2 calcium imaging assay ( C ) and quantification of repeats ( D ) showing reconstitution of SOCE in STX11-depleted Jurkat T cells by ectopic expression of STX11. Scr shRNA with empty vector (EV) expression (black), STX11 shRNA with EV expression (red), STX11 shRNA with STX11 expression (green). (n=30–40 cells/group, N=3). ( E ) Sanger sequencing of FHLH4 patient DNA showing deletion of a single adenine at the 752nd position and the resulting frameshift. ( F ) Schematic showing the predicted domain distribution of the wildtype versus FHLH4 mutant STX11 protein. ( G ) Western blot on WCLs of healthy donor (HD) and FHLH4 patient PBMCs showing the relative molecular weight and abundance of the wildtype and mutant STX11 bands (red arrow). ( H ) Western blot on WCLs of HEK293 cells over-expressing wildtype or FHLH4 mutant STX11 (red arrow) and empty vector. ( I ) Fura-2 calcium imaging assay measuring anti-CD3 induced SOCE in HD (black) and FHLH4 (red) T cells. (n=30–40 cells/group). ( J ) Fura-2 calcium imaging assay measuring SOCE in HD expressing empty vector (EV) (black) and FHLH4 T cells expressing human STX11 (red), respectively. (n=30–40 cells/group). ( K–L ) Representative Fura-2 calcium imaging assay ( K ) and quantification of repeats ( L ) measuring SOCE in Jurkat T cells treated either with Scr shRNA expressing empty vector (EV) (black), STX11 shRNA expressing EV (red), STX11 shRNA expressing wildtype STX11 (green), or STX11 shRNA expressing FHLH4 mutant STX11 (blue). Figure 1—source data 1. Numerical data underlying the quantitative analyses represented in . Figure 1—source data 2. Folder containing the original sequencing result files, shown in . Figure 1—source data 3. Folder containing labeled PDF files of the original western blots for . Figure 1—source data 4. Folder containing the original images of western blots displayed in .

Article Snippet: Cell line ( Homo sapiens ) , Jurkat T cell line [Clone E6-1] , ATCC , TIB-152 (RRID: CVCL_0367 ) , — and and associated figure supplements .

Techniques: Calcium Imaging, Expressing, shRNA, Plasmid Preparation, DNA Sequencing, Mutagenesis, Western Blot, Molecular Weight, Sequencing, Labeling, Knockdown

Journal: eLife

Article Title: Syntaxin11 deficiency inhibits CRAC channel priming to suppress cytotoxicity and gene expression in T lymphocytes independent of membrane trafficking

doi: 10.7554/eLife.111335

Figure Lengend Snippet:

Article Snippet: Cell line ( Homo sapiens ) , Jurkat T cell line [Clone E6-1] , ATCC , TIB-152 (RRID: CVCL_0367 ) , — and and associated figure supplements .

Techniques: